Lion Corporation
LIOPY
Other OTC16.40
USD
- -
- -
ISIN
US5361971063
CUSIP
536197106
Return %
Stock
S&P500
1Y
- -
26.53
3Y
-15.81
76.60
5Y
-65.83
80.11
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Masayuki Takemori
- Full Time Employees
- 7,654
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- Address
- 3-7, Honjo 1-chome Tokyo Japan 130-8644
- IPO Date
- Mar 16, 2020
- Website
- lion.co.jp
- Similar Companies
- Business
- Lion Corporation (TSE: 4912; OTC: LIOPY) manufactures and sells a broad range of consumer products focused on daily hygiene and health needs, including toothpastes, toothbrushes, soaps, detergents, shampoos, rinses, cosmetics, fabric care items, dishwashing products, cooking-related goods, over-the-counter pharmaceuticals, and health supplements; it also produces industrial products such as chemical activators derived from oils and fats, and exports to overseas affiliates. The company operates through consumer products, industrial products, and overseas business segments, serving markets primarily in Japan, Thailand, Malaysia, Vietnam, China, Korea, Indonesia, Singapore, Hong Kong, and Taiwan with brands emphasizing oral care (where it leads Japan in toothpastes and toothbrushes), beauty care, fabric care, living care, and pharmaceuticals. Founded in 1891 and headquartered at 1-3-28 Kuramae, Taito-ku, Tokyo, Japan, Lion employs 7,654 people on a consolidated basis and reported net sales of ¥412.9 billion in fiscal year 2024. In recent developments, Lion signed a partnership agreement with Japan Activation Capital, Inc. in October 2024, under which JAC acquired common shares to support sustainable growth, profitability improvements in domestic consumer products, and overseas business expansion as part of the company's Vision2030 1st STAGE medium-term plan. Additionally, in April 2025, Lion announced the acquisition of the remaining 64% stake in equity-method affiliate Merap Lion Holding Corporation in Vietnam, converting it into a wholly owned subsidiary to enhance synergies in product development, production technology, and healthcare distribution networks covering hospitals, clinics, and pharmacies. These moves align with Lion's strategic shift to strengthen its overseas portfolio and integrate local strengths for greater market penetration in Southeast Asia.